Illumina Selected as Preferred Partner for UK's 100,000 Genomes Project | GenomeWeb

NEW YORK (GenomeWeb) – Illumina said in a regulatory filing this week that Genomics England has selected Illumina Cambridge as a preferred partner for the 100,000 Genomes Project.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.